维多利祖马布
克罗恩病
医学
期限（时间）
疾病
内科学
物理
量子力学
作者
Séverine Vermeire,Edward V. Loftus,Jean‐Frédéric Colombel,Brian G. Feagan,William J. Sandborn,Bruce E. Sands,Silvio Danese,Geert D’Haens,Arthur Kaser,Remo Panaccione,David T. Rubin,Ira Shafran,Megan McAuliffe,Arpeat Kaviya,Serap Sankoh,Reema Mody,Brihad Abhyankar,Michael Smyth
标识
DOI：10.1093/ecco-jcc/jjw176
摘要
The clinical benefits of vedolizumab continued with long-term treatment regardless of prior TNF antagonist exposure. Increased dosing frequency might improve outcomes in patients who lose response to conventional 8-weekly dosing.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
嘻嘻哈哈
AllRightReserved
GingerF
Nexus
HFH
ccm
栗子
Rainyin
闪闪的忆枫
OK
无极微光
光明磊落陈2011
369ninja
贪玩的秋柔
Satal
Bruce
七月流火
123
想起了拥抱
loii
皖公网安备34019202002308
